Mineralys Therapeutics (MLYS) Non-Current Assets (2022 - 2026)
Mineralys Therapeutics' Non-Current Assets came in at $2.05 million for Q2 2026, up 350.8% from $455,000 a year earlier and up 423.2% from the prior quarter.
Powered by 
Analysis
Mineralys Therapeutics (MLYS) Non-Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, Mineralys Therapeutics' Non-Current Assets was $420,000, down 23.9% from FY2024.
- Non-Current Assets carries a three-year compound annual growth rate of -36.4% (FY2022 to FY2025).
- Going back by year, Non-Current Assets was $552,000 in FY2024 (-78.2%), $2.53 million in FY2023 (+55.3%) and $1.63 million in FY2022.
- The Q2 2026 figure represents the highest quarterly Non-Current Assets since Q4 2023.
- Year-over-year, Non-Current Assets increased in two of the last eight quarters, with growth averaging 8.2%.
- The fastest year-over-year change in Non-Current Assets over five years came in Q2 2026 (growth of 350.8%), and the weakest in Q1 2024 (a decline of 98.6%).
- Business Quant data shows MLYS's Non-Current Assets at $392,000 (Q1 2026), $420,000 (Q4 2025) and $151,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Mineralys Therapeutics | 1.83 Bn | -731.88 Mn | - | 2.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.05 Mn |
| Mar 31, 2026 | 392,000.00 |
| Dec 31, 2025 | 420,000.00 |
| Sep 30, 2025 | 151,000.00 |
| Jun 30, 2025 | 455,000.00 |
| Mar 31, 2025 | 435,000.00 |
| Dec 31, 2024 | 552,000.00 |
| Sep 30, 2024 | 521,000.00 |
| Jun 30, 2024 | 491,000.00 |
| Mar 31, 2024 | 430,000.00 |
| Dec 31, 2023 | 2.53 Mn |
| Sep 30, 2023 | 12.18 Mn |
| Jun 30, 2023 | 21.73 Mn |
| Mar 31, 2023 | 31.16 Mn |
| Dec 31, 2022 | 1.63 Mn |
API Access
Mineralys Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=MLYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "MLYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=MLYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();